Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.
- DOI
- 10.1016/s0140-6736(24)02842-3
- Published
- 2025 Mar 1
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-24-02842-3,
title = {Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.},
author = {Couturaud F and Schmidt J and Sanchez O and Ballerie A and Sevestre MA and Meneveau N and Bertoletti L and Connault J and Benhamou Y and Constans J and Quemeneur T and Lapébie FX and Pernod G and Picart G and Elias A and Doutrelon C and Neveux C and Khider L and Roy PM and Zuily S and Falvo N and Lacroix P and Emmerich J and Mahé I and Boileau J and Yaici A and Le Jeune S and Stéphan D and Plissonneau-Duquene P and Ray V and des Déserts MD and Belhadj-Chaidi R and Lamia B and Gruel Y and Presles E and Girard P and Tromeur C and Moustafa F and Rothstein V and Lacut K and Melac S and Barillot S and Mismetti P and Laporte S and Mottier D and Meyer G and Leroyer C and RENOVE Investigators},
year = {2025},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(24)02842-3},
url = {https://doi.org/10.1016/s0140-6736(24)02842-3}
}RIS
TY - JOUR TI - Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial. AU - Couturaud F AU - Schmidt J AU - Sanchez O AU - Ballerie A AU - Sevestre MA AU - Meneveau N AU - Bertoletti L AU - Connault J AU - Benhamou Y AU - Constans J AU - Quemeneur T AU - Lapébie FX AU - Pernod G AU - Picart G AU - Elias A AU - Doutrelon C AU - Neveux C AU - Khider L AU - Roy PM AU - Zuily S AU - Falvo N AU - Lacroix P AU - Emmerich J AU - Mahé I AU - Boileau J AU - Yaici A AU - Le Jeune S AU - Stéphan D AU - Plissonneau-Duquene P AU - Ray V AU - des Déserts MD AU - Belhadj-Chaidi R AU - Lamia B AU - Gruel Y AU - Presles E AU - Girard P AU - Tromeur C AU - Moustafa F AU - Rothstein V AU - Lacut K AU - Melac S AU - Barillot S AU - Mismetti P AU - Laporte S AU - Mottier D AU - Meyer G AU - Leroyer C AU - RENOVE Investigators PY - 2025 JO - Lancet (London, England) DO - 10.1016/s0140-6736(24)02842-3 UR - https://doi.org/10.1016/s0140-6736(24)02842-3 ER -
APA
F, C., J, S., O, S., A, B., MA, S., N, M., L, B., J, C., Y, B., J, C., T, Q., FX, L., G, P., G, P., A, E., C, D., C, N., L, K., PM, R., S, Z., N, F., P, L., J, E., I, M., J, B., A, Y., S, L. J., D, S., P, P., V, R., MD, D. D., R, B., B, L., Y, G., E, P., P, G., C, T., F, M., V, R., K, L., S, M., S, B., P, M., S, L., D, M., G, M., C, L., & Investigators, R. (2025). Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)02842-3
Source records
- pubmed · retrieved 2026-09-25T17:35:01.111Z
- europe-pmc · retrieved 2026-09-25T17:35:01.140Z
- hal · retrieved 2026-09-25T17:35:01.154Z